I saw Zoe Adams again today on 15th May 2023 accompanied by her mother.
As you are aware, Zoe has a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD), predominantly inattentive type. Recent assessments indicate a potential comorbid anxiety disorder, which we are monitoring closely.
On the whole, I am extremely pleased with Zoe's progress. Her concentration has improved significantly, particularly in school settings. However, some challenges persist in social interactions, possibly related to emerging anxiety symptoms.
We discussed implementing cognitive behavioral strategies to address Zoe's anxiety. I've provided her family with resources on relaxation techniques and mindfulness exercises suitable for adolescents.
Zoe remains on Methylphenidate 30mg once daily, which has been effective in managing her ADHD symptoms. We're considering adding a low dose of Sertraline to address the anxiety, pending further evaluation.
I plan to see Zoe again in 6 weeks to reassess her progress and decide on potential anxiety medication. In the meantime, please monitor for any adverse effects from her current medication regimen. If you have any concerns, please don't hesitate to contact me on 0412 345 678.